The expression of SMOC1 was significantly correlated with the survival of six cancer types, including brain glioma, colorectal cancer, eye uveal melanoma, breast cancer, LUAD, and ovarian cancer (Table 1). Here, SMOC1 is linked to colorectal cancer.